Press releases
2022
30 Jun 2022, 12:30 | Regulatory
30 Jun 2022, 08:00
16 Jun 2022, 07:00 | Regulatory
30 May 2022, 16:00 | Regulatory
30 May 2022, 15:55
The Nomination Committee in Hansa Biopharma has completed its nomination work for the Annual General Meeting 2022. It proposes to the Annual General Meeting 2022 for Peter Nicklin to be elected new chair of the Board of Directors of Hansa Biopharma. The current chair Ulf Wiinberg has chosen to not stand for re-election.
23 May 2022, 08:00
· 30 patients with active or chronic active antibody mediated rejection (AMR) episodes post kidney transplantation have been enrolled and randomized 2:1 to imlifidase v.s. standard-of-care
· Completion of enrollment marks an important milestone for Hansa, as the company explores the potential of imlifidase in the post transplantation setting.
· Acute AMR episod…
13 May 2022, 08:00
21 Apr 2022, 08:00 | Regulatory
· Solid sales growth in Q1 2022
· Market access secured in Germany and in France
· Marketing authorization granted in Israel
· Results from Phase 2 program in anti-GBM published in Journal of American Society of Nephrology (JASN)
